Read on Twitter
On the heels of @pfizer #COVID19 #vaccine, @moderna_tx today announced its mRNA vax also works, but better -- 95% effective. And they say it is stable at normal freezer temperatures, unlike the Pfizer product. https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-longer-shelf-life-its-covid-19-vaccine
2/
Other diffs w/ @pfizer vax -- @Moderna #COVID19 #vaccine was tested in >30K volunteers, a booster was required, and they were tested for #SARSCoV2 infection 14dys later (Pfizer was just 7 days).
They rpt more side effects.
MORE https://investors.modernatx.com/news-releases/news-release-details/modernas-covid-19-vaccine-candidate-meets-its-primary-efficacy
Other diffs w/ @pfizer vax -- @Moderna #COVID19 #vaccine was tested in >30K volunteers, a booster was required, and they were tested for #SARSCoV2 infection 14dys later (Pfizer was just 7 days).
They rpt more side effects.
MORE https://investors.modernatx.com/news-releases/news-release-details/modernas-covid-19-vaccine-candidate-meets-its-primary-efficacy
3/
The @moderna_tx press release states: "2% in frequency after the first dose included injection site pain (2.7%), & after the 2nd dose included fatigue (9.7%), myalgia (8.9%), arthralgia (5.2%), headache (4.5%), pain (4.1%) & erythema/redness at the injection site (2.0%)."
MORE
The @moderna_tx press release states: "2% in frequency after the first dose included injection site pain (2.7%), & after the 2nd dose included fatigue (9.7%), myalgia (8.9%), arthralgia (5.2%), headache (4.5%), pain (4.1%) & erythema/redness at the injection site (2.0%)."
MORE
4/
These side effects are mild, & @moderna_tx says they all resolved quickly.
Press release says, "By the end of 2020, the Company expects to have approx 20 million doses of mRNA-1273 ready to ship in the U.S. [and will] manufacture 500M to 1 billion doses globally in 2021."
MORE
These side effects are mild, & @moderna_tx says they all resolved quickly.
Press release says, "By the end of 2020, the Company expects to have approx 20 million doses of mRNA-1273 ready to ship in the U.S. [and will] manufacture 500M to 1 billion doses globally in 2021."
MORE
5/
As with the @Pfizer #vaccine announcement, @moderna_tx is conducting science by press release. There is no scientific review or peer analysis. So, as w/Pfizer's vax, it's euphoria w/out data.
Wall St. will jump, anyway. And Moderna added a caveat section.
MORE
As with the @Pfizer #vaccine announcement, @moderna_tx is conducting science by press release. There is no scientific review or peer analysis. So, as w/Pfizer's vax, it's euphoria w/out data.
Wall St. will jump, anyway. And Moderna added a caveat section.
MORE
6/ @moderna_tx says,
"The forward-looking statements in this press release are neither promises nor guarantees, & you should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors..."
MORE
"The forward-looking statements in this press release are neither promises nor guarantees, & you should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors..."
MORE
7/
"...many of which are beyond Moderna’s control & which could cause actual results to differ materially from those expressed or implied by these forward-looking statements. These risks, uncertainties, & other factors include, among others:"
MORE
"...many of which are beyond Moderna’s control & which could cause actual results to differ materially from those expressed or implied by these forward-looking statements. These risks, uncertainties, & other factors include, among others:"
MORE
8/
"...the fact that there has never been a commercial product utilizing mRNA technology approved for use; the fact that the rapid response tech in use by @moderna_tx is still being developed & implemented; the fact that the safety & efficacy of mRNA-1273 has not yet..."
MORE
"...the fact that there has never been a commercial product utilizing mRNA technology approved for use; the fact that the rapid response tech in use by @moderna_tx is still being developed & implemented; the fact that the safety & efficacy of mRNA-1273 has not yet..."
MORE
9/
"...been established; the @US_FDA or such other regulatory agencies may not agree w/the Company’s regulatory approval strategies, components of our filings, such as clinical trial designs, conduct & methodologies, or the sufficiency of data submitted;..."
MORE
"...been established; the @US_FDA or such other regulatory agencies may not agree w/the Company’s regulatory approval strategies, components of our filings, such as clinical trial designs, conduct & methodologies, or the sufficiency of data submitted;..."
MORE
10/
"...potential adverse impacts due to the global #COVID19 #pandemic such as delays in regulatory review, manufacturing & clinical trials, supply chain interruptions, adverse effects on healthcare systems & disruption of the global economy" https://investors.modernatx.com/news-releases/news-release-details/modernas-covid-19-vaccine-candidate-meets-its-primary-efficacy
"...potential adverse impacts due to the global #COVID19 #pandemic such as delays in regulatory review, manufacturing & clinical trials, supply chain interruptions, adverse effects on healthcare systems & disruption of the global economy" https://investors.modernatx.com/news-releases/news-release-details/modernas-covid-19-vaccine-candidate-meets-its-primary-efficacy
